On June 30, 2026, the National Institutes of Health announced that its All of Us Research Program has become the world’s largest integrated ...

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...

The premise is straightforward — we are awash in biological data. The rapid growth of multiomics datasets (genomics, transcriptomics, proteomics, metabolomics, and radiomics) together with ...

Drug repurposing — the identification of new therapeutic indications for approved drugs or clinical-stage candidates — offers one of the most efficient strategies to deliver new treatments to patients ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

NEW YORK--(BUSINESS WIRE)--The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New York City, unveiling advances that mark a pivotal ...

Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development. Under the new ...

The US Food and Drug Administration (FDA) has issued a warning letter to Purolea Cosmetics Lab for several violations of Good Manufacturing Practices (GMP). Notably, the warning letter calls the ...

Researchers have screened thousands of approved drugs against a network of 2,358 longevity-linked genes, producing a shortlist of compounds that may slow biological aging without new drug development.

With the help of artificial intelligence, a coalition of Bay Area institutions identified 18 FDA-approved drugs that could improve the lives of those suffering from amyotrophic lateral sclerosis, ...

CSIR-IICT scientists have used AI-driven structural bioinformatics to identify a promising repurposed drug candidate against poxviruses, including Mpox and Lumpy Skin Disease Virus.